Document is current
Any future updates will be listed below
-
Authors
Andersen, Per Normann https://orcid.org/0000-0002-0242-7230
Orm, Stian https://orcid.org/0000-0002-4932-8264
Fossum, Ingrid Nesdal https://orcid.org/0000-0002-6217-6154
Øie, Merete Glenne https://orcid.org/0000-0003-0308-2462
Skogli, Erik Winther https://orcid.org/0000-0002-8450-2176
-
Funding
Funding for this research was provided by:
Sykehuset Innlandet HF (150610, 150624, 150648, 150610, 150624, 150648, 150610, 150624, 150648, 150610, 150624, 150648, 150610, 150624, 150648)
Norwegian Centre of Expertise for Neurodevelopmental DIsorders (150616, 150616, 150616, 150616, 150616)
- License Information
-
More Information
Article History
Received: 2 September 2022
Accepted: 27 February 2023
First Online: 9 March 2023
Declarations
:
: We conducted the study following the Helsinki Declaration of the World Medical Association Assembly. Participation was voluntary. Children aged 12 years and older and their parents gave informed written consent before inclusion at T1 and T2, while children below 12 years of age gave verbal consent before inclusion. At T3, all participants gave their informed written consent. The participants received monetary compensation for their efforts (500 NOK) and their traveling expenses related to testing were covered. Verbal informed consent together with written informed consent from parents of children less than 16 years together with the study as a whole was approved by the Regional Committee for Medical Research Ethics in Eastern Norway (T1, T2; REK east 62009-24) and Regional Committee for Medical Research Ethics in Southern and Eastern Norway (T3: 2018/1611/REK south-east) as well as the privacy ombudsman for research at the Innlandet Hospital Trust (nr. 95495).
: Not applicable.
: The authors declare that they have no competing interests.
